The Department of Psychiatry

MOUNT SINAI'S DEPARTMENT of Psychiatry is one of the most productive in the nation. In 2021, we were ranked No. 7 in National Institutes of Health (NIH) funding for psychiatry, published more than 850 papers, completed more than 800,000 outpatient visits, and received $49 million in active grants.

In 2021, we also launched three new centers, which represent our commitment to innovation and meeting the needs of our patients:

* The Center for Psychedelic Psychotherapy and Trauma Research studies unconventional treatment methods such as MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD), depression, and anxiety in veterans and civilians.

* The Center for Computational Psychiatry is one of the world’s first integrated programs to study how quantitative tools and methodologies can improve the diagnosis and treatment of mental health issues, such as addiction, eating disorders, autism, and personality disorders.

* The Jeff and Lisa Blau Adolescent Consultation Center for Resilience and Treatment will focus on schizophrenia and serve as a clinical and research platform to increase our understanding of this devastating mental illness, which typically emerges before or during adolescence. The center will use the latest tools in clinical data science, artificial intelligence, and genomics to create groundbreaking clinical care and research.

In this report you will also read about our latest advances in deep brain stimulation, the use of ketamine for post-traumatic stress disorder, and how human organoid models are helping to answer specific questions about the brain.

This has been a busy year for our department, and we are proud of our achievements. We invite you to read more about Mount Sinai's research and clinical advances in this report.